BioSpace News Archive

SYNAPS Dx, a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease, is pleased to announce the release of its white paper, “Resolving a Diagnostic Dilemma.”

Guardant Health, Inc. (Nasdaq: GH) today presented additional data from the ECLIPSE study at 2023 Digestive Disease Week (DDW) titled, “Clinical Validation of a Cell-Free DNA Blood-Based Test for Colorectal Cancer in an Average Risk Population” (Abstract #913e) showcasing the performance of its blood-based technology to accurately detect early-stage colorectal cancer (CRC).

The Insight Partners published latest research report on “Travel Vaccines Market Size Report, Share, Trends & Growth Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Application”,

Led by researchers from NYU Grossman School of Medicine and University of Szeged in Hungary, a new study in mice and rats found that restoring certain signals in a brain region that processes smells countered depression.

Alkermes plc announced the acceptance of two abstracts related to nemvaleukin alfa, the company’s novel, investigational, engineered interleukin-2 variant immunotherapy, for presentation at the American Society of Clinical Oncology Annual Meeting, taking place in Chicago June 2-6, 2023.

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2023.

Seres Therapeutics, Inc., a leading microbiome therapeutics company, reported first quarter 2023 financial results and provided business updates.

908 Devices Inc. today reported financial results for the quarter ended March 31, 2023.

Spectrum Pharmaceuticals, Inc. announced today financial results for the three-month period ended March 31, 2023, and provided a corporate update.

Vedanta Biosciences today announced that management will participate in a fireside chat and host investor meetings at the JMP Securities Life Sciences Conference being held May 15-16, 2023 at the New York Hilton Midtown in New York, NY.